
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination
Bin Ju, Qing Fan, Congcong Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112532-112532
Open Access | Times Cited: 16
Bin Ju, Qing Fan, Congcong Liu, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112532-112532
Open Access | Times Cited: 16
Showing 16 citing articles:
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 15
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 15
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Yunji Liao, Hang Ma, Zhenyu Wang, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants
Qi Gui, Haiyan Wang, Congcong Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Qi Gui, Haiyan Wang, Congcong Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies
Miao Wang, Congcong Liu, Qing Fan, et al.
The Journal of Immunology (2025)
Closed Access
Miao Wang, Congcong Liu, Qing Fan, et al.
The Journal of Immunology (2025)
Closed Access
A Hidden Guardian: The Stability and Spectrum of Antibody-Dependent Cell-Mediated Cytotoxicity in COVID-19 Response in Chinese Adults
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Jinge Cao, Mengze Gan, Zhihao Zhang, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 262-262
Open Access
Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies
Pavel P. Solodkov, Alexander M. Najakshin, Nikolai A. Chikaev, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 129-129
Open Access | Times Cited: 3
Pavel P. Solodkov, Alexander M. Najakshin, Nikolai A. Chikaev, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 129-129
Open Access | Times Cited: 3
Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection
Sergey V. Kulemzin, Sergey V. Guselnikov, Boris G. Nekrasov, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 55-55
Open Access | Times Cited: 1
Sergey V. Kulemzin, Sergey V. Guselnikov, Boris G. Nekrasov, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 55-55
Open Access | Times Cited: 1
Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1
Jiali Wang, Bingjie Shi, Hanyi Chen, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 417-417
Open Access | Times Cited: 1
Jiali Wang, Bingjie Shi, Hanyi Chen, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 417-417
Open Access | Times Cited: 1
Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Zuowei Wang, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Zuowei Wang, Ling Li, Ruiping Du, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Zuowei Wang, Ling Li, Ruiping Du, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111557-111557
Open Access | Times Cited: 1
Zuowei Wang, Ling Li, Ruiping Du, et al.
iScience (2024) Vol. 28, Iss. 1, pp. 111557-111557
Open Access | Times Cited: 1
Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants
Norika Nagasawa, Ryusuke Kimura, Mao Akagawa, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2336-2336
Open Access | Times Cited: 2
Norika Nagasawa, Ryusuke Kimura, Mao Akagawa, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2336-2336
Open Access | Times Cited: 2
A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants
Sergey V. Guselnikov, Konstantin O. Baranov, Sergey V. Kulemzin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Sergey V. Guselnikov, Konstantin O. Baranov, Sergey V. Kulemzin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case
Takeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
EBioMedicine (2024) Vol. 110, pp. 105439-105439
Closed Access
Takeo Kuwata, Yu Kaku, Shashwata Biswas, et al.
EBioMedicine (2024) Vol. 110, pp. 105439-105439
Closed Access
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including BQ and XBB lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Ling Li, Xixian Chen, Zuowei Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineages dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access